Personalized medicine, endotypes, and intensive care medicine

Intensive Care Medicine

Volumn 41, Issue 6, 2015, Pages 1138-1140

  Wong, Hector R ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADRENAL GLAND; CLINICAL DECISION MAKING; COMORBIDITY; CORTICOTROPIN TEST; CRITICALLY ILL PATIENT; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; GENETIC VARIABILITY; HORMONE SUBSTITUTION; IMMUNE RESPONSE; INTENSIVE CARE UNIT; MICROBIOME; MORTALITY; PATHOGEN LOAD; PERSONALIZED MEDICINE; PHARMACEUTICAL CARE; SINGLE NUCLEOTIDE POLYMORPHISM; FEMALE; HUMAN; MALE; MULTIPLE ORGAN FAILURE; PHENOTYPE; SEPSIS; SHOCK, SEPTIC;

FEMALE; HUMANS; MALE; MULTIPLE ORGAN FAILURE; PHENOTYPE; SEPSIS; SHOCK, SEPTIC;

EID: 84931957160     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-015-3812-3     Document Type: Editorial

References (14)

1. Holst L (2015) The Precision Medicine Initiative: data-driven treatments as unique as your own body. https://www.whitehouse.gov/blog/2015/01/30/precision-medicine-initiative-data-driven-treatments-unique-your-own-body. Accessed 1 Apr 2015
2. Collins FS, Varmus H (2015) A new initiative on precision medicine. N Engl J Med 372:793–795
3. Marshall JC (2008) Sepsis: rethinking the approach to clinical research. J Leukoc Biol 83:471–482
4. Wong HR, Lindsell CJ, Pettila V, Meyer NJ, Thair SA, Karlsson S, Russell JA, Fjell CD, Boyd JH, Ruokonen E, Shashaty MG, Christie JD, Hart KW, Lahni P, Walley KR (2014) A multibiomarker-based outcome risk stratification model for adult septic shock. Crit Care Med 42:781–789
5. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaud P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871
6. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111–124
7. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165–228
8. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, Cheval C, Monchi M, Teboul JL, Riche F, Leleu G, Arbibe L, Mignon A, Delpech M, Dhainaut JF (1999) Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282:561–568
9. Meyer NJ, Feng R, Li M, Zhao Y, Sheu CC, Tejera P, Gallop R, Bellamy S, Rushefski M, Lanken PN, Aplenc R, O’Keefe GE, Wurfel MM, Christiani DC, Christie JD (2013) IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist. Am J Respir Crit Care Med 187:950–959
10. Meyer NJ, Ferguson JF, Feng R, Wang F, Patel PN, Li M, Xue C, Qu L, Liu Y, Boyd JH, Russell JA, Christie JD, Walley KR, Reilly MP (2014) A functional synonymous coding variant in the IL1RN gene is associated with survival in septic shock. Am J Respir Crit Care Med 190:656–664
11. Dinarello CA, van der Meer JW (2013) Treating inflammation by blocking interleukin-1 in humans. Semin Immunol 25:469–484
12. Knox DB, Lanspa MJ, Kuttler KG, Brewer SC, Brown SM (2015) Phenotypic clusters within sepsis-associated multiple organ dysfunction syndrome. Intensive Care Med. doi:10.1007/s00134-015-3764-7
13. Wong HR, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, Weiss SL, Fitzgerald J, Checchia PA, Meyer K, Shanley TP, Quasney M, Hall M, Gedeit R, Freishtat RJ, Nowak J, Shekhar RS, Gertz S, Dawson E, Howard K, Harmon K, Beckman E, Frank E, Lindsell CJ (2015) Developing a clinically feasible personalized medicine approach to pediatric septic shock. Am J Respir Crit Care Med 191:309–315
14. Maslove DM, Wong HR (2014) Gene expression profiling in sepsis: timing, tissue, and translational considerations. Trends Mol Med 20:204–213